QQ客服 官方微博 反馈留言

	Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China
	Liu, Jiaye; Qiu, Shaohui; Lu, Jingjing; Yan, Bingyu; Feng, Yi; Li, Li; Zhang, Guomin; Wang, Fuzhen; He, Peng; Fang, Xin
刊名	JOURNAL OF INFECTIOUS DISEASES
	2017
卷号	216期号:3页码:327-335
关键词	chronic hepatitis C hepatitis B vaccine anti-HBs cell-mediated immunity
DOI	10.1093/infdis/jix295
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4589433
专题	山东大学
作者单位	Shandong Univ, Acad Prevent Med, 16992 Jingshi Rd, Jinan 250014, Shandong, P
推荐引用方式 GB/T 7714	Liu, Jiaye,Qiu, Shaohui,Lu, Jingjing,et al. Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China[J]. JOURNAL OF INFECTIOUS DISEASES,2017,216(3):327-335.
APA	Liu, Jiaye.,Qiu, Shaohui.,Lu, Jingjing.,Yan, Bingyu.,Feng, Yi.,...&Hu, Zhong 更多.(2017).Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China.JOURNAL OF INFECTIOUS DISEASES,216(3),327-335.
MLA	Liu, Jiaye,et al."Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-Treatment Patients With Chronic Hepatitis C: An Open-Label Control Study in China".JOURNAL OF INFECTIOUS DISEASES 216.3(2017):327-335.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。